You just read:

ProMetic enters into strategic agreements with ProThera Biologics to develop plasma-derived Inter-alpha Inhibitor Proteins ("IAIP") for orphan diseases

News provided by

ProMetic Life Sciences Inc.

Nov 19, 2015, 06:30 EST